Kim et al reported the impact of nonalbumin proteinuria on prediction of nephropathy progression in a patient with Type 2 diabetes. The combination of albuminuria and nonalbumin proteinuria can improve risk stratification. The authors are from Pusan National University and Kim Yong Ki Internal Medicine Clinic in South Korea.
